Skip to main content
Fig. 9 | Journal of Hematology & Oncology

Fig. 9

From: Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021

Fig. 9

FDA-approved therapeutic drugs for thyroid cancer and other solid tumors. a Recombinant human thyroid-stimulating hormone (obtained from www.rcsb.org and go.drugbank.com). b & c Multitargeted TKIs. d 9-cis-retinoic acid. e DNA alkylating agent. f PDGFRα-directed mAb. g CSF1R, KIT, and FLT3 inhibitor. h EZH2 inhibitor. i DNA alkylating agent. j GD2‑directed mAbs. k Folate analog. l TRKs inhibitor

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us